Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden · Delayed Price · Currency is SEK 11.00
+0.04 (0.36%)
Jun 16, 2026, 9:00 AM CET
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of 2.98 billion as of June 15, 2026. Its market cap has increased by 48.33% in one year.
Market Cap
2.98B
Enterprise Value
1.92B
Revenue
3.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.00
Market Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from 87.82M to 2.98B, an increase of 3,291.78%. That is a compound annual growth rate of 39.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 2.98B | -6.37% |
| Dec 30, 2025 | 3.18B | 60.49% |
| Dec 30, 2024 | 1.98B | 25.12% |
| Dec 29, 2023 | 1.58B | 8.13% |
| Dec 30, 2022 | 1.47B | 46.67% |
| Dec 30, 2021 | 998.90M | -47.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.51B |
| Egetis Therapeutics AB | 2.46B |
| Flerie AB | 2.01B |
| Saniona AB | 1.78B |
| BioInvent International AB | 1.59B |
| Genovis AB (publ.) | 1.29B |
| Medivir AB | 930.82M |
| Infant Bacterial Therapeutics AB | 821.76M |